Anu Mahadevan

3.0k total citations
59 papers, 2.4k citations indexed

About

Anu Mahadevan is a scholar working on Pharmacology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Anu Mahadevan has authored 59 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Pharmacology, 21 papers in Cellular and Molecular Neuroscience and 11 papers in Organic Chemistry. Recurrent topics in Anu Mahadevan's work include Cannabis and Cannabinoid Research (40 papers), Neurotransmitter Receptor Influence on Behavior (17 papers) and Forensic Toxicology and Drug Analysis (9 papers). Anu Mahadevan is often cited by papers focused on Cannabis and Cannabinoid Research (40 papers), Neurotransmitter Receptor Influence on Behavior (17 papers) and Forensic Toxicology and Drug Analysis (9 papers). Anu Mahadevan collaborates with scholars based in United States, Italy and United Kingdom. Anu Mahadevan's co-authors include Raj K. Razdan, Billy R. Martin, Jenny L. Wiley, Aron H. Lichtman, Vincenzo Di Marzo, P. L. Fuchs, Bijali Saha, Tiziana Bisogno, Roger G. Pertwee and James J. Burston and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Neuroscience and Biochemical and Biophysical Research Communications.

In The Last Decade

Anu Mahadevan

59 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anu Mahadevan United States 30 1.8k 878 355 338 307 59 2.4k
Thomas Elebring Sweden 12 1.3k 0.7× 680 0.8× 393 1.1× 233 0.7× 243 0.8× 25 2.0k
Michele K. McKinney United States 10 1.6k 0.9× 554 0.6× 485 1.4× 313 0.9× 183 0.6× 10 2.0k
Michael H. Bracey United States 9 1.9k 1.0× 1.0k 1.2× 505 1.4× 273 0.8× 368 1.2× 11 2.5k
Marco Allarà Italy 26 1.6k 0.9× 588 0.7× 534 1.5× 259 0.8× 206 0.7× 56 2.3k
Lamont Booker United States 8 1.6k 0.9× 746 0.8× 304 0.9× 281 0.8× 350 1.1× 10 1.8k
Juha R. Savinainen Finland 23 1.2k 0.7× 559 0.6× 604 1.7× 215 0.6× 190 0.6× 56 1.8k
Francis Barth France 21 3.3k 1.8× 2.3k 2.6× 630 1.8× 223 0.7× 652 2.1× 33 3.8k
Kay Ahn United States 13 1.2k 0.7× 448 0.5× 765 2.2× 230 0.7× 135 0.4× 18 2.4k
Gemma L. Baillie United Kingdom 13 1.4k 0.7× 892 1.0× 506 1.4× 162 0.5× 229 0.7× 19 1.8k
Martin Kaczocha United States 27 1.8k 1.0× 852 1.0× 795 2.2× 328 1.0× 253 0.8× 69 2.7k

Countries citing papers authored by Anu Mahadevan

Since Specialization
Citations

This map shows the geographic impact of Anu Mahadevan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anu Mahadevan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anu Mahadevan more than expected).

Fields of papers citing papers by Anu Mahadevan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anu Mahadevan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anu Mahadevan. The network helps show where Anu Mahadevan may publish in the future.

Co-authorship network of co-authors of Anu Mahadevan

This figure shows the co-authorship network connecting the top 25 collaborators of Anu Mahadevan. A scholar is included among the top collaborators of Anu Mahadevan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anu Mahadevan. Anu Mahadevan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Pelleg, Amir, et al.. (2023). DT-0111: a novel P2X3 receptor antagonist. Purinergic Signalling. 19(3). 467–479. 3 indexed citations
3.
Ramirez, Servio H., János Haskó, Shongshan Fan, et al.. (2012). Activation of Cannabinoid Receptor 2 Attenuates Leukocyte–Endothelial Cell Interactions and Blood–Brain Barrier Dysfunction under Inflammatory Conditions. Journal of Neuroscience. 32(12). 4004–4016. 192 indexed citations
4.
Ghosh, Sudeshna, Laura E. Wise, Yugang Chen, et al.. (2012). The monoacylglycerol lipase inhibitor JZL184 suppresses inflammatory pain in the mouse carrageenan model. Life Sciences. 92(8-9). 498–505. 99 indexed citations
5.
Bátkai, Sándor, Partha Mukhopadhyay, Béla Horváth, et al.. (2011). Δ8‐Tetrahydrocannabivarin prevents hepatic ischaemia/reperfusion injury by decreasing oxidative stress and inflammatory responses through cannabinoid CB2 receptors. British Journal of Pharmacology. 165(8). 2450–2461. 39 indexed citations
6.
Kinsey, Steven G., Anu Mahadevan, Pattipati S. Naidu, et al.. (2010). The CB2 cannabinoid receptor-selective agonist O-3223 reduces pain and inflammation without apparent cannabinoid behavioral effects. Neuropharmacology. 60(2-3). 244–251. 82 indexed citations
7.
Booker, Lamont, Pattipati S. Naidu, Raj K. Razdan, Anu Mahadevan, & Aron H. Lichtman. (2009). Evaluation of prevalent phytocannabinoids in the acetic acid model of visceral nociception. Drug and Alcohol Dependence. 105(1-2). 42–47. 40 indexed citations
8.
Bisogno, Tiziana, James J. Burston, Marco Allarà, et al.. (2009). Synthesis and Pharmacological Activity of a Potent Inhibitor of the Biosynthesis of the Endocannabinoid 2‐Arachidonoylglycerol. ChemMedChem. 4(6). 946–950. 44 indexed citations
9.
Burston, James J., Laura J. Sim‐Selley, Anu Mahadevan, et al.. (2008). N-Arachidonyl Maleimide Potentiates the Pharmacological and Biochemical Effects of the Endocannabinoid 2-Arachidonylglycerol through Inhibition of Monoacylglycerol Lipase. Journal of Pharmacology and Experimental Therapeutics. 327(2). 546–553. 36 indexed citations
10.
Crocker, Peter J., Anu Mahadevan, Jenny L. Wiley, Billy R. Martin, & Raj K. Razdan. (2007). The role of fluorine substitution in the structure–activity relationships (SAR) of classical cannabinoids. Bioorganic & Medicinal Chemistry Letters. 17(6). 1504–1507. 6 indexed citations
11.
Roy, Sucharita, Jenny L. Wiley, Billy R. Martin, et al.. (2007). Novel, potent THC/anandamide (hybrid) analogs. Bioorganic & Medicinal Chemistry. 15(24). 7850–7864. 12 indexed citations
12.
Liu, Jie, Lei Wang, Judith Harvey‐White, et al.. (2007). Multiple pathways involved in the biosynthesis of anandamide. Neuropharmacology. 54(1). 1–7. 235 indexed citations
13.
Martin, Billy R., Jenny L. Wiley, I. P. Beletskaya, et al.. (2006). Pharmacological Characterization of Novel Water-Soluble Cannabinoids. Journal of Pharmacology and Experimental Therapeutics. 318(3). 1230–1239. 26 indexed citations
14.
McHugh, Douglas, Roger G. Pertwee, Sucharita Roy, et al.. (2006). Novel Compounds That Interact with Both Leukotriene B4 Receptors and Vanilloid TRPV1 Receptors. Journal of Pharmacology and Experimental Therapeutics. 316(2). 955–965. 24 indexed citations
15.
Bisogno, Tiziana, Maria Grazia Cascio, Bijali Saha, et al.. (2006). Development of the first potent and specific inhibitors of endocannabinoid biosynthesis. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1761(2). 205–212. 106 indexed citations
16.
Ligresti, Alessia, Maria Grazia Cascio, Gareth Pryce, et al.. (2005). New potent and selective inhibitors of anandamide reuptake with antispastic activity in a mouse model of multiple sclerosis. British Journal of Pharmacology. 147(1). 83–91. 53 indexed citations
17.
Wiley, Jenny L., et al.. (2002). Resorcinol Derivatives: A Novel Template for the Development of Cannabinoid CB1/CB2 and CB2-Selective Agonists. Journal of Pharmacology and Experimental Therapeutics. 301(2). 679–689. 48 indexed citations
18.
19.
20.
Gensler, Walter J., et al.. (1956). Preparation and Constitution of Nonadiyne-1,4. Journal of the American Chemical Society. 78(1). 163–167. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas Elebring Breakdown of academic impact, for papers by Michele K. McKinney Breakdown of academic impact, for papers by Michael H. Bracey Breakdown of academic impact, for papers by Marco Allarà Breakdown of academic impact, for papers by Lamont Booker Breakdown of academic impact, for papers by Juha R. Savinainen Breakdown of academic impact, for papers by Francis Barth Breakdown of academic impact, for papers by Kay Ahn Breakdown of academic impact, for papers by Gemma L. Baillie Breakdown of academic impact, for papers by Martin Kaczocha
Rankless by CCL
2026